The European Union’s drugs regulator has given the green light to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting conditional marketing authorization to the two-dose vaccine made by U.S. biotech company Novavax
TORONTO — Bars, restaurants, stores and entertainment venues across the Canadian province of Quebec will be required to operate at 50% capacity because of the omicron variant of the coronavirus.